proanthocyanidin has been researched along with Carcinoma, Hepatocellular in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
He, X; Li, M; Liu, G; Shen, X; Shi, A; Tao, Y; Tu, Q; Wang, N; Wang, Q; Yin, C; Yin, H | 1 |
Dauer, A; Hensel, A; Knasmüller, S; Lhoste, E; Mersch-Sundermann, V | 1 |
2 other study(ies) available for proanthocyanidin and Carcinoma, Hepatocellular
Article | Year |
---|---|
Polyphenolic Proanthocyanidin-B2 suppresses proliferation of liver cancer cells and hepatocellular carcinogenesis through directly binding and inhibiting AKT activity.
Topics: Animals; Apoptosis; Carcinogenesis; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Liver Neoplasms; Mice; Molecular Docking Simulation; Phosphatidylinositol 3-Kinases; Proanthocyanidins; Proto-Oncogene Proteins c-akt | 2020 |
Genotoxic and antigenotoxic effects of catechin and tannins from the bark of Hamamelis virginiana L. in metabolically competent, human hepatoma cells (Hep G2) using single cell gel electrophoresis.
Topics: Anthocyanins; Antineoplastic Agents, Phytogenic; Benzo(a)pyrene; Carcinoma, Hepatocellular; Catechin; Cytochrome P-450 CYP1A1; DNA Damage; Electrophoresis, Agar Gel; Gallic Acid; Hamamelis; Hexoses; Humans; Liver Neoplasms; Mutagens; Plant Bark; Proanthocyanidins; Tumor Cells, Cultured | 2003 |